Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

519 results

Curious mitral and tricuspid scenarios

16 Nov 2025 – From PCR London Valves 2025

This session presents a series of challenging and unusual clinical scenarios involving mitral and tricuspid valve disease. Topics include management of acute primary mitral regurgitation in high-surgical-risk patients, technical challenges in transcatheter mitral valve replacement (TMVR), and complex cases where cardiac rhythm disturbances interplay with valvular...

Tricuspid valve interventions in complex scenarios

16 Nov 2025 – From PCR London Valves 2025

This session explores tricuspid valve interventions in complex clinical scenarios, emphasizing emerging techniques such as electrosurgical laceration to enable TTVR, emergency TEER for papillary muscle rupture, and expanded options for difficult valve disease. It also addresses procedural challenges when conventional implantation maneuvers fail, transcatheter alternatives for...

Cutting-edge research in transcatheter tricuspid valve therapies

16 Nov 2025 – From PCR London Valves 2025

This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.

Cutting-edge research in transcatheter tricuspid valve therapies

Hotline - Mitral and tricuspid valvular interventions

16 Nov 2025 – From PCR London Valves 2025

This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...

Shaping the future: top innovations at PCR London Valves 2025

16 Nov 2025 – From PCR London Valves 2025

Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...

Complex mitral and tricuspid TEER

16 Nov 2025 – From PCR London Valves 2025

This session highlights complex cases in mitral and tricuspid transcatheter edge-to-edge repair (TEER), addressing challenges such as septal obstacles in patients with old atrial septal occluders, management of residual atrial septal defects post-mitral valve-in-ring replacement, and innovative multidisciplinary approaches. It also covers hybrid transapical mitral valve-in-valve...

Focus on the right ventricle: patient selection and clinical outcomes after tricuspid valve intervention

16 Nov 2025 – From PCR London Valves 2025

Focused on the often-overlooked right ventricle, this session elucidates methods for accurate assessment of right ventricular function prior to transcatheter tricuspid valve interventions. It explores the role of right heart catheterisation in patient selection and timing, and evaluates long-term remodeling patterns post-procedure, providing critical insights for...

Focus on the right ventricle: patient selection and clinical outcomes after tricuspid valve intervention

Transcatheter tricuspid valve replacement: who to treat and how to implement into my practice

12 Nov 2025

In this on-demand webinar, F. Praz, P. Lurz, M. Adam, and T. Patterson explore TTVR, sharing key insights and the latest clinical evidence supporting TTVR.

Transcatheter tricuspid valve replacement: who to treat and how to implement into my practice

TRIGISTRY: Advancing real-world understanding of tricuspid valve disease

07 Nov 2025

Edoardo Zancanaro interviews Julien Dreyfus and David Messika-Zeitoun about TRIGISTRY, an international registry that builds on the TRI-SCORE — now part of the 2025 ESC guidelines. The study confirms that early referral and optimal reduction of tricuspid regurgitation are key to improving outcomes. The team now...

TRIGISTRY insights

How will the new valvular guidelines impact my tricuspid programme?

16 Oct 2025

Watch this replay with F. Maisano, J. Dreyfus, J. Hausleiter and M. Sitges to get familiar with new recommendations regarding the treatment of the tricuspid valve and so much more!

How will the new valvular guidelines impact my tricuspid programme?